Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Ordinary Shares, par value CHF 0.05 per share
-
Shares outstanding
-
66.4M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
20.8M
-
Shares change
-
-826K
-
Total reported value, excl. options
-
$54.6M
-
Value change
-
-$2.24M
-
Number of buys
-
14
-
Number of sells
-
-13
-
Price
-
$2.63
Significant Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q3 2022
37 filings reported holding SOPH - SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share as of Q3 2022.
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.8M shares
of 66.4M outstanding shares and own 31.26% of the company stock.
Largest 10 shareholders include GENERATION INVESTMENT MANAGEMENT LLP (6.79M shares), BANQUE PICTET & CIE SA (2.17M shares), CREDIT SUISSE AG/ (1.85M shares), PRINCIPAL FINANCIAL GROUP INC (1.46M shares), Alta Wealth Advisors LLC (1.41M shares), JENNISON ASSOCIATES LLC (1.24M shares), GENERAL ELECTRIC CO (1.11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (956K shares), PURA VIDA INVESTMENTS, LLC (896K shares), and PFM Health Sciences, LP (880K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.